search
Back to results

Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role? (EXP DIAL)

Primary Purpose

Chronic Kidney Diseases

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Dialysis without physical exercise
Dialysis with pre-dialytic physical exercise
Dialysis with per-dialytic physical exercise
Sponsored by
University Hospital, Montpellier
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Chronic Kidney Diseases focused on measuring Chronic kidney disease on dialysis, Physical exercise, Regional myocardial function, Myocardial stunning

Eligibility Criteria

20 Years - 79 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient aged ≥ 20 to ≤ 79 years
  • Undernourished patient according to the ARNOS score : ≥ 2
  • No medical contraindication to physical activity
  • Life expectancy greater than 6 months
  • Patient on hemodialysis for more than 3 months
  • Patients with relatively good echogenicity

Exclusion Criteria:

  • Patient is participating in another Category I interventional study, or has participated in another interventional study within the past 3 months
  • The patient is in an exclusion period determined by a previous study
  • The patient is under legal protection or under guardianship or curatorship
  • It turns out to be impossible to give the patient informed information, or the patient refuses to sign the consent
  • Pregnant, parturient or breastfeeding patient
  • Patient with a contraindication to retraining
  • Patient with valvular heart disease, arteriopathy of the lower limbs stage III and IV, amputation or knee or hip prosthesis
  • Patient with musculoskeletal problems
  • Patient with severe respiratory failure
  • Paired sleep apnea syndrome
  • BMI> 35
  • Patient with automatic implantable defibrillator
  • Heart transplant
  • Uncontrolled high blood pressure
  • Ejection fraction <45%
  • Unstabilized coronaries
  • Non-contributory stress ultrasound

Sites / Locations

  • Lapeyronie Hospital clinical trials Department
  • AIDER SantéRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Patients issued from dialysis units (clinic)

Arm Description

Outcomes

Primary Outcome Measures

Change in regional myocardial function and myocardial stunning

Secondary Outcome Measures

Change in blood viscosity
Change in arterial stiffness
Change in sinus rhythm
Change in dialysis efficacy
Change in inflammatory markers
Change in mineral and bone metabolism markers
Change in myokines
Change in cardiac remodeling markers

Full Information

First Posted
April 1, 2021
Last Updated
December 31, 2021
Sponsor
University Hospital, Montpellier
Collaborators
AIDER- Santé, Avignon University (EA4278 - LaPEC), Pr Philippe OBERT, Dr Claire MAUFRAIS
search

1. Study Identification

Unique Protocol Identification Number
NCT04831021
Brief Title
Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role?
Acronym
EXP DIAL
Official Title
Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role?
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Recruiting
Study Start Date
September 24, 2021 (Actual)
Primary Completion Date
October 2022 (Anticipated)
Study Completion Date
April 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier
Collaborators
AIDER- Santé, Avignon University (EA4278 - LaPEC), Pr Philippe OBERT, Dr Claire MAUFRAIS

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims at evaluating, in chronic kidney disease patients on dialysis, the effect of acute per- or pre-dialytic physical exercise on regional myocardial function and myocardial stunning, blood viscosity, arterial stiffness, variability of sinus rhythm, dialysis efficacy, inflammation, mineral and bone disorders, myokines and cardiac remodeling markers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Kidney Diseases
Keywords
Chronic kidney disease on dialysis, Physical exercise, Regional myocardial function, Myocardial stunning

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
All patients will be assigned to one dialysis session without physical exercise, one dialysis session with pre-dialytic physical exercise and one dialysis session with per-dialytic physical exercise in random order.
Masking
None (Open Label)
Allocation
N/A
Enrollment
32 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Patients issued from dialysis units (clinic)
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Dialysis without physical exercise
Intervention Description
Hemodialysis control condition
Intervention Type
Procedure
Intervention Name(s)
Dialysis with pre-dialytic physical exercise
Intervention Description
Patients will pedal for 30 minutes using a ergometer directly attached to the dialysis bed. The exercise will be performed 60 minutes before connection to hemodialysis.
Intervention Type
Procedure
Intervention Name(s)
Dialysis with per-dialytic physical exercise
Intervention Description
Patients will pedal for 30 minutes using a ergometer directly attached to the dialysis bed. The exercise will start 30 minutes after the start of dialysis.
Primary Outcome Measure Information:
Title
Change in regional myocardial function and myocardial stunning
Time Frame
Weekly over a period of 3 weeks
Secondary Outcome Measure Information:
Title
Change in blood viscosity
Time Frame
Weekly over a period of 3 weeks
Title
Change in arterial stiffness
Time Frame
Weekly over a period of 3 weeks
Title
Change in sinus rhythm
Time Frame
Weekly over a period of 3 weeks
Title
Change in dialysis efficacy
Time Frame
Weekly over a period of 3 weeks
Title
Change in inflammatory markers
Time Frame
Weekly over a period of 3 weeks
Title
Change in mineral and bone metabolism markers
Time Frame
Weekly over a period of 3 weeks
Title
Change in myokines
Time Frame
Weekly over a period of 3 weeks
Title
Change in cardiac remodeling markers
Time Frame
Weekly over a period of 3 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient aged ≥ 20 to ≤ 79 years Undernourished patient according to the ARNOS score : ≥ 2 No medical contraindication to physical activity Life expectancy greater than 6 months Patient on hemodialysis for more than 3 months Patients with relatively good echogenicity Exclusion Criteria: Patient is participating in another Category I interventional study, or has participated in another interventional study within the past 3 months The patient is in an exclusion period determined by a previous study The patient is under legal protection or under guardianship or curatorship It turns out to be impossible to give the patient informed information, or the patient refuses to sign the consent Pregnant, parturient or breastfeeding patient Patient with a contraindication to retraining Patient with valvular heart disease, arteriopathy of the lower limbs stage III and IV, amputation or knee or hip prosthesis Patient with musculoskeletal problems Patient with severe respiratory failure Paired sleep apnea syndrome BMI> 35 Patient with automatic implantable defibrillator Heart transplant Uncontrolled high blood pressure Ejection fraction <45% Unstabilized coronaries Non-contributory stress ultrasound
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jean Paul CRISTOL, MD, PhD
Phone
04 67 33 83 14
Email
jp-cristol@chu-montpellier.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean Paul CRISTOL, MD, PhD
Organizational Affiliation
CHU Lapeyronie, Department of Biochemistry and Hormonology, Montpellier, FRANCE
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
François ROUBILLE, MD, PhD
Organizational Affiliation
CHU ADV, Department of Cardiology, Montpellier, FRANCE
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Cécile TURC-BARON, MD
Organizational Affiliation
AIDER Santé, Montpellier, FRANCE
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Jérôme ADDA, MD
Organizational Affiliation
CHU ADV, Department of Cardiology, Montpellier, FRANCE
Official's Role
Study Chair
Facility Information:
Facility Name
Lapeyronie Hospital clinical trials Department
City
Montpellier
State/Province
Hérault
ZIP/Postal Code
34295
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean Paul CRISTOL, MD, PhD
Phone
04 67 33 83 14
Email
jp-cristol@chu-montpellier.fr
Facility Name
AIDER Santé
City
Montpellier
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Cécile TURC-BARON, MD

12. IPD Sharing Statement

Learn more about this trial

Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role?

We'll reach out to this number within 24 hrs